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Aims  To compare long-term trends in wastewater data with other indicators of 
stimulant use in three locations and to test the reliability of estimates based on one 
week of sampling. 
Design  Comparison of trends in quantities (‘loads’) of stimulants or their metabolites 
in wastewater with trends in other indicators of stimulant use (e.g. treatment, police, 
population survey data).  
Setting and Participants Populations in Oslo (Norway), South-East Queensland 
(Australia) and Eindhoven (The Netherlands).  
Measurements Wastewater data were modelled for MDMA (3,4-Methylenedioxy
methamphetamine), benzoylecgonine (a metabolite of cocaine), amphetamine and 
methamphetamine in Oslo; benzoylecgonine in Eindhoven; and methamphetamine 
in South-East Queensland. Choice of stimulants modelled in each region was 
primarily determined by availability of useable data.  
Findings  In Oslo, wastewater data, driving under the influence of drugs statistics 
and seizure data all suggested increasing MDMA use between 2009 and 2017. In 
South-East Queensland, there was an estimated 31.1% (95%CI 29.4-32.9%) annual 
increase in daily loads of methamphetamine in wastewater between 2009 and 2016, 
compared with a 14.1% (95%CI 10.9-17.3%) annual increase in seizures. Some of 
the increase in wastewater can be explained by increased purity. In Eindhoven, there 
was no evidence of a change in cocaine consumption from wastewater, but a 
reduction was observed in numbers in treatment for cocaine use from 2012 to 2017. 
In approximately half the cases examined in Oslo, credible intervals around 
estimates of annual average loads from a regression model versus estimates based 
on a single week of sampling did not overlap.  
Conclusions  Long-term trends in loads of stimulants in wastewater appear to be 
broadly consistent with trends in other indicators of stimulant use in three locations. 
Wastewater data should be interpreted alongside epidemiological indicators and 
purity data. One week of wastewater sampling may not be sufficient for valid 
inference about drug consumption.  
Keywords: 	
Sewage epidemiology, Long-term trends, Bayesian analysis, Methamphetamine, 
MDMA, Queensland, Oslo. 
 
Introduction 
Analysis of wastewater samples is a novel technique for observing patterns of 
community drug use (1). The method, known as ‘wastewater-based epidemiology’ or 
WBE, was first used in 2005 to investigate illicit drug use (2) and has become an 
increasingly popular approach for making inferences about drug consumption in the 
population. 
The approach involves collection of samples of raw sewage from the inlet of a 
wastewater treatment plant (WWTP), with the flow rate recorded for each sample. 
The samples are analysed for concentrations of specific drug target residues, which 
can be measured with great accuracy and precision (3, 4). These concentrations and 
flow rates are used to estimate daily loads (e.g. in g/day), which are estimates of the 
total amount of drug target residue arriving at the treatment plant. These are divided 
by estimates of the size of the population connected to the WWTP to produce 
estimated population-normalised daily loads (5, 6), i.e. the amount of drug target 
residue arriving at the treatment plant each day, per 1000 people served by the 
treatment plant. 
An ongoing European multi-city study (7) analyses one week of daily wastewater 
samples each year from many cities across Europe. These data are published by the 
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) as a 
complementary national indicator of drug consumption (8). Very few locations with 
large populations have collected wastewater data over longer time frames. There 
has therefore been very limited exploration of how much variation can be expected in 
wastewater samples over a longer time period (9) and therefore of how 
representative any single week might be of one year. 
No single measure can provide a full picture of regional drug use and current trends 
(10, 11). A multi-indicator approach is required, incorporating commensurate data 
such as population surveys and police data (12-20). Several of the previous 
comparisons of wastewater data with other indicators of drug consumption have 
been limited by the single week of sampling issue. In this paper, we examine data 
from three case study locations in which more frequent and long-term wastewater 
data are available.  
The specific aims of this study were: 
1. To compare long-term trends in loads of stimulant drug target residues in 
wastewater data with trends in more traditional indicators of stimulant use, in 
three locations. 
2. To explore whether one week of daily wastewater samples, typically 
undertaken in current surveillance exercises (7), can estimate daily average 




We identified three sites with populations greater than 200,000 people where regular 
wastewater data and commensurate epidemiological data were available over 
several years, from which we could compare trends in stimulant use: Oslo (Norway), 
South-East Queensland (Australia) and Eindhoven (The Netherlands). We focused 
on four stimulant drug target residues: benzoylecgonine (a metabolite of cocaine 
(21)), amphetamine, methamphetamine and MDMA. The choice of locations, and of 
which of the four stimulants to model in each location, was primarily determined by 
availability of useable data. 
We acquired other regional indicators of stimulant consumption that matched the 
catchment of the WWTPs as closely as possible. Where this was not viable, we 
obtained national data.  
Measures 
Oslo 
We amalgamated eight Oslo wastewater datasets, some of which have been 
analysed previously, e.g. (22-24). This includes the 1-week snapshots published by 
the EMCDDA each year from 2011-2017 (8), referred to herein as ‘EMCDDA data’. 
These datasets had not previously been merged and analysed together, allowing 
long-term trends to be assessed. The combined data covers the period 2009 to 2017 
and relates to a WWTP serving approximately two-thirds of the population of Oslo, 
primarily the western side (roughly 550,000 people). We present the results for 
MDMA in this article to provide a contrast to the other case studies. The results for 
methamphetamine, amphetamine and benzoylecgonine are given in the Supporting 
Information. 246 samples were analysed for MDMA in total, with a median of 24 
samples per year (ranging from 7 samples per year in 2011 and 2013, to a maximum 
of 58 samples in 2016).  
For each stimulant, we also examined annual numbers of people Driving Under the 
Influence of drugs (DUI) recorded by the police in Oslo (25) and annual numbers of 
police seizures (26) in Oslo, Asker and Bærum, over the same timeframe. Over 
similar timeframes, we examined annual national indicators of stimulant use in 
Norway. This included numbers of positive results from autopsy ((27), personal 
communications from Gerrit Middelkoop, Oslo University Hospital), numbers of 
people in treatment (28), prevalence estimates from general population surveys 
(GPS) and numbers of positive drug tests in prison (Oslo University Hospital).  
South East (SE) Queensland 
In recent years indicators have consistently evidenced an increase in 
methamphetamine use in Australia (29-32), whereas indicators of use for other 
stimulants have been relatively flat (33, 34). In SE Queensland, we therefore 
examined data relating to methamphetamine use only.  
The wastewater data span the period 2009 to 2017 and relate to a WWTP serving 
approximately 230,000 inhabitants. 598 daily samples were analysed, with a median 
of 49 samples per year (ranging from 12 in 2009 to 188 in 2012). Some of the earlier 
parts of the dataset have been reported on previously, e.g. (17, 34-37). 
We also examined the annual number of methamphetamine seizures in SE 
Queensland from 2010-2015 (17) and annual numbers of methamphetamine-related 
hospital admissions, emergency department presentations and psychiatric 
admissions in the state (Queensland) from 2010-2015/16 (29). Furthermore, we 
examined national annual numbers of methamphetamine-related deaths from 2009-
2015 (32). We also obtained regional purity data from seizures of methamphetamine 
in SE Queensland, provided by the Queensland Health Forensic Chemistry 
Laboratory and Bruno et al. (2018, (17)).  
Eindhoven 
Although ‘long-term’ wastewater data in Eindhoven have been collected for each 
drug target residue of interest, direct disposals of unconsumed amphetamine and 
MDMA contaminated a considerable number of the daily samples (6), potentially 
indicating nearby production. Since it is unknown the quantity of each drug disposed 
of in this way, these could not be considered a reliable indicator of consumption (38, 
39). Levels of methamphetamine in wastewater were at an extremely low level 
throughout the timespan of the data and there were no other indicators of 
methamphetamine consumption to compare with. Consequently, we modelled only 
the benzoylecgonine data. The wastewater data cover the period 2012 to 2017 and 
are from a WWTP serving an estimated population of 450,300 people in Eindhoven 
and several surrounding towns and villages. The wastewater data comprise of 187 
daily samples in total. However, for the years 2012-2015 the data are much more 
limited than for the other two locations, consisting only of seven days of EMCDDA 
data (15 days in 2012). In addition to the EMCDDA data from 2016 and 2017, there 
were consecutive daily samples for approximately 3 months from May-July 2016 and 
seven weeks in July-August 2017. 
We examined monthly cocaine treatment demand data for the Eindhoven region 
from 2012 to 2017. More specifically, the data consisted of the total number of 
people who attended treatment in each month with cocaine as their primary or 
secondary problem. This data set corresponds to a very similar geographical area to 
the WWTP catchment area, making comparisons with wastewater data more 
relevant. We also obtained cocaine-related national annual numbers of recorded DUI 
offences and deaths from 2013-2016 (40). 
Statistical analysis 
Modelling the wastewater data 
We adopted a Bayesian statistical approach, which is well suited to modelling 
multiple sources of uncertainty and potentially complex hierarchical data structures.	
We accounted for three sources of sampling uncertainty in estimated population-
normalised loads: analytical uncertainty in the concentration measurements, 
uncertainty in the daily flow estimates and uncertainty in the estimated population 
size served by the WWTP (41). These were determined by the authorship team to be 
the important sources of sampling variability when considering long-term trends. We 
extended the approach previously described (41) to a hierarchical log-linear 
regression modelling approach, in which we further accounted for three sources of 
temporal variation: 
(1) Systematic differences in daily population-normalised loads by day of the 
week. 
(2) Differences in monthly average population-normalised loads. We fitted three 
alternative models to these monthly averages on the log scale: 
(i) Annual effects model. Step change by calendar year  
(ii) Annual and quarterly effects model. Step change by year and by 
quarter of the year  
(iii) Linear trend model. Linear regression on month since first sample 
(3) An additional amount of random daily variation around the fitted trend line 
within each month (assumed constant). 
A log-linear modelling approach was used due to positive skewness in the data and 
to prevent negative fitted values. The basic functional form of the model was decided 
a priori, based on previous evidence and consideration of the characteristics of the 
data. For example, systematic differences in loads by day of the week are well 
established in the literature ((9),(23),(37)). Pragmatic decisions had to be made 
about modelling of systematic changes over time (models (i) to (iii) above) due to 
limited data availability: for example, there were insufficient data to include ‘month’ 
effects or year-by-quarter interaction terms in model (ii). Model (iii) was fitted 
specifically to facilitate comparison of long term trends with other indicators, through 
estimated gradients. 
Models were fitted in WinBUGS (42), using all of the available wastewater data. The 
deviance information criterion (DIC) (43) was used to compare the fit after penalising 
for complexity of models (i) to (iii). This is a Bayesian generalisation of the Akaike 
information criterion, with models with lower DIC values preferred. In the Results 
section, for each stimulant and location we display annual estimates based on model 
(iii) and the best fitting of models (i) and (ii). 
More information about the regression models and the assumptions made about 
uncertainties in the concentration, flow and population size parameters in each 
location is provided in the Supporting Information (S1). 
Analysis of other regional and national indicators of stimulant use 
Data such as annual or monthly numbers of seizures, hospital admissions, positive 
autopsy results, numbers in treatment and recorded offences for DUI were analysed 
using Poisson regression models, with time (year or month) as a covariate. A logistic 
regression model with year as a covariate was fitted to annual prevalence data from 
population surveys. These simple models were fitted as rough approximations only, 
to facilitate comparison of overall trends with the wastewater data. These analyses 
were performed in R. 
Comparison of trends 
We estimated annual percentage changes in population-normalised loads of 
stimulants in wastewater (based on model (iii) above) and in other indicators of 
stimulant consumption based on the regression models with time as a covariate. We 
compare these percentages with caution, since we would not anticipate changes in 
total population consumption to manifest in the same way across indicators. For 
example, a doubling in total consumption would not necessarily lead to a doubling of 
number of individuals in treatment. 
Purity-adjustment in South East Queensland 
Seizure data indicate that methamphetamine purity in SE Queensland varied 
considerably across the wastewater sampling period (17): increasing substantially 
from approximately 12.7% (95% confidence interval, CI, 9.6 to 15.9%) purity in 2009 
to 68.8% (95% CI 67.2 to 70.3%) in 2015, then decreasing slightly to 60.8% (95% CI 
57.7 to 64.0%) in 2017. To explore the potential impact of this, we produced purity-
adjusted annual population-normalised loads of methamphetamine, by dividing 
annual estimates from the best fitting of our wastewater models by estimated 
percentage purity. Our simulations-based modelling approach provides estimates 
with 95% credible interval (Cr-Is) that account for uncertainty in estimates of 
percentage purity, in addition to the sources of uncertainty described above.  
Comparison of annual daily averages from EMCDDA data and non-EMCDDA data 
In Oslo and Eindhoven (which both contribute data to the annual EMCDDA 
estimation exercise), we compared results from EMCDDA and non-EMCDDA data 
for years in which there were 21 or more wastewater samples in addition to the 
EMCDDA data. We compared the following two estimates of average daily 
population-normalised loads in each year: 
(i) based on analysis of the one week of EMCDDA data per year in isolation, 
accounting for uncertainty in concentration, flow and population 
parameters (41).  
(ii) based on the best fitting of the three regression models above, applied to 
all available wastewater data except for the EMCDDA data. EMCDDA data 
were removed here to avoid biasing the comparison in favour of 
agreement.  
We note that comparisons could only be made in Eindhoven for benzoylecgonine in 
2016 and 2017, where data were available only for March to August in each year. 
We also compared the EMCDDA-based estimates with estimates based on any 
other seven-day consecutive period of sampling in the same year.  
Results 
1. MDMA use in Oslo 
Recorded numbers of DUI MDMA offences and police seizures in Oslo increased 
annually on average over the timeframe of the data (Table 1; Figure 1). At the 
national level, there was also an increase in estimated prevalence of use and in 
annual numbers of positive results from autopsy and prison data (Table 1; Figure 1). 
Daily population-normalised loads of MDMA in wastewater (Figure 2A) show a very 
large amount of variability, even among samples taken close together in time. This is 
particularly evident in 2014, where estimates range from 1.7 to 170.7 mg/day per 
1000 people. Also plotted are the estimated daily average population-normalised 
loads for each year, based on model (i) and model (iii). From model (iii), average 
daily population-normalised loads are estimated to have increased over time (Table 
1), but model (i) has a slightly better fit to the data (Table 2): this estimates a general 
increasing trend, but with some evidence of a peak in 2015 and extremely low values 
in 2011.    
Part of the observed variability in wastewater loads is likely due to variation by day of 
the week: as shown in Figure 2B, there is evidence of loads being higher on average 
on weekends versus week days. 
Use of other stimulants in Oslo 
Long-term trends in methamphetamine measured in wastewater generally agreed 
with trends in other indicators of methamphetamine use in Oslo and Norway, all of 
which decreased over the timeframe of the wastewater data. There were no clear 
long-term trends in wastewater (or other indicators) for amphetamine or cocaine use. 
Full results for these other stimulants are provided in Supporting Information S2.  
2. Methamphetamine use in SE Queensland 
All indicators of methamphetamine use at regional, state and national level 
suggested increasing use over the timeframe of the data (Table 3; Figure 3).  
The crude (unadjusted for purity) wastewater data (Figure 4A) are also consistent 
with a large increase in methamphetamine use from 2009 to 2016. There was also 
evidence of systematic variation by day of the week (Figure 4B). Model (iii) estimates 
an average annual increase in daily population-normalised loads between 2009 and 
2017 (Table 3). However, this linear trend model does not fit the data well (Table 2), 
due to strong evidence of a reduction in loads between 2016 and 2017. The more 
flexible model (ii) fits the data better (Table 2) and estimates a 32.3% (95% Cr-I 22.3 
to 41.1%) reduction in average daily loads between these two years. Since data from 
the other indicators examined are not yet available for 2017, it is not yet possible to 
ascertain whether the recent reduction according to the wastewater data is reflected 
in other indicators.  
Estimates of the purity of methamphetamine in SE Queensland between 2009 and 
2017 are shown in the Supporting Information (S1.3). After adjusting for changes in 
purity, the estimated trend looks quite different (Figure 4A – red). Purity-adjusted 
estimates varied less across years (estimated 2.4 fold variation across annual 
estimates, versus 9.0 fold prior to adjusting for purity). As indicated on the plot, the 
total amount of (impure) methamphetamine consumed by the population may have 
actually reduced in 2012 and 2013 relative to 2010, subsequently rising again, with a 
large peak in consumption in 2016.  
3. Cocaine use in Eindhoven 
There was an overall reduction in the number of people attending treatment in 
Eindhoven with cocaine as their primary or secondary problem between 2012 and 
2017 (Table 4; Figure 5A– although we note the large amount of overdispersion 
around the fitted trend line). In contrast, nationally there was an increase in numbers 
of recorded DUI offences per year and recorded cocaine-related deaths (Table 4; 
Figure 5B). 
The daily averaged population-normalised loads of benzoylecgonine plotted in 
Figure 6A show a very large amount of variability, even among samples taken close 
together in time, and no clear temporal trend. Model (iii) provided little evidence of 
change over time (Table 4), but model (i) fitted the data much better (Table 2) and 
gave strong evidence of a reduction in daily loads on average between 2016 and 
2017. There is evidence of a delayed weekend effect (Figure 6B): the WWTP has 
advised us that this is likely due to the retention time in the system prior to reaching 
the treatment plant.  
Estimating annual loads from one week of sampling 
Estimates of annual average daily wastewater loads based on EMCDDA and non- 
EMCDDA data are displayed for Oslo in Figure 7. The two sets of credible intervals 
(red versus green) did not overlap in approximately 50% of the cases. Furthermore, 
the credible intervals from the EMCDDA data (red) did not overlap with other weekly 
averages from the same year (blue) in approximately 40% of the cases. For 
Eindhoven in 2016 and 2017 the EMCDDA versus non- EMCDDA based credible 




In Oslo, long-term trends in wastewater data were broadly consistent with evidence 
from more traditional epidemiological indicators: in particular, suggesting an increase 
in MDMA use between 2009 and 2017. Loads of methamphetamine in wastewater 
increased drastically in SE Queensland between 2009 and 2016, consistent with 
large increases observed in numbers of methamphetamine-related deaths, hospital 
admissions and seizures. Observed increases in methamphetamine loads in 
wastewater appear to be partly driven by changes in purity, which may also be an 
important driver of increases in methamphetamine-related harms (hospital 
admissions and deaths). In Eindhoven, where the wastewater data are much more 
sparse in time, wastewater data did not evidence a clear trend in cocaine 
consumption, whereas there was a large reduction in treatment demand for cocaine 
problems during the same time period.  
Across all three locations that we studied, there was a large amount of variability in 
daily population-normalised loads of stimulants in wastewater. Although some of this 
variability can be explained by weekend effects (particularly for MDMA), there was 
clear residual variation beyond this. One or two weeks of wastewater sampling can 
raise hypotheses about differences in drug use by geographical area. However, 
based on our comparisons of estimates based on just seven days (‘EMCDDA data’) 
and estimates based on longer term sampling in Oslo and Eindhoven, we cannot be 
confident that inferences based on just one week are robust. 
Strengths and Limitations 
We compared long-term trends in wastewater data with other indicators of stimulant 
use in three locations over a timeframe of up to nine years, much longer than 
previous studies. We developed and applied a Bayesian hierarchical regression 
model that allows for uncertainty in concentration, flow and population parameters 
and also multiple sources of temporal variation in loads. We fitted log-linear or linear 
trend models as approximations for all indicators, to facilitate comparison of long 
term trends across data sets. We compared fit with some slightly more flexible 
models for the wastewater data, but not for the other indicators, such that estimated 
coefficients (Tables 1, 3, 4) should be interpreted with caution. The linearity 
assumption was clearly violated in some specific instances (e.g. Supplementary 
materials Figure S2.3: seizures and prison data).  
We note that it was difficult to identify suitable locations for this study, since there are 
few wastewater data sets with more than 1-2 weeks of samples per year over a 
number of years. Further, wastewater data generally relate to a local level (city, or 
some fraction of a city served by a particular treatment plant), for which other 
indicators of stimulant use are not necessarily available. We therefore had to use 
national data to compare trends of some indicators with wastewater data; these 
comparisons should be treated with caution as it is difficult to assess how 
representative these selected cities are for the country as a whole. In addition, other 
indicators are often available only as annual counts and are not always stimulant-
specific. We also acknowledge that epidemiological data also can give uncertain, 
incomplete and biased perspectives on drug use trends in the population – but we 
lacked sufficient information to identify and adjust for inconsistencies in the evidence. 
For example, information was not available on levels of police activity, changes in 
which could affect trends in DUI and/or seizure data. We could not adjust wastewater 
loads for purity in Oslo or Eindhoven as regional purity data were not available. 
Estimated population-normalised loads of drug target residues in wastewater will be 
biased if inaccurate population size estimates are used in the standardisation. We 
used population size estimates provided by the WWTPs, usually based on census 
data. The level of uncertainty that we allowed for in these estimates (see Supporting 
Information S1) may not be sufficient to allow for the bias. More accurate estimates 
of the size of the population served by a WWTP could be obtained through mobile 
phone, ammonia or biomarker data (35, 44-46). Future research should continue to 
investigate cost-effective approaches to accurately estimate ‘de facto’ population 
size, to minimise the use of inaccurate census-based estimates in wastewater 
calculations. 
Comparison with Other Evidence  
Other studies that have used a multi-indicator approach (12-20) have also found a 
general agreement between trends in drug target residues in wastewater and trends 
in other indicators of drug consumption. Our study was conducted over a much 
longer time frame and accounts for multiple sources of uncertainty, such as the 
concentration measurements, the daily flow estimates and the estimated population 
sizes, through our Bayesian hierarchical regression model.  
Our finding that one week of wastewater sampling may not be sufficient is in 
agreement with the study of Ort et al (9), which presented an analysis of 1369 
consecutive days of sampling in a German village with approximately 7160 
inhabitants. They reported an approximate 60% relative error in estimates of annual 
means based on any one week of samples (9). To date, no formula has been 
derived to determine the minimum number of samples required for robust inference 
across all scenarios.  
Bruno et al (17) noted that changes in purity of methamphetamine may be a key 
driver of observed increases in loads in wastewater in SE Queensland, which we 
extended to provide purity-adjusted estimates over a longer time-period.  We 
included new data which shows that both purity and wastewater loads of 
methamphetamine in SE Queensland have very recently reduced. It will be 
interesting to see whether such a reduction is later reflected in other indicators of use 
and harm and, if so, how much of a time lag there is before such a reduction can be 
detected from other time series data. We note that analysis of Finnish data has 
previously suggested that wastewater analysis could provide an ‘early warning’ of 
changes in drug consumption, before such changes are evident from other indicators 
(18). 
Implications 
Changes in street purity could be a key driver of observed changes of drug target 
residues in wastewater and indeed of changes in other indicators of use. Where 
possible, trends in purity data should be assessed and, if appropriate, adjusted for. 
Further research is required to determine the minimum sampling period for 
wastewater data to be meaningful as an annual indicator of drug consumption. The 
issue is complicated by the fact that this will vary by the prevalence and frequency of 
drug use in the population studied and the ratio of episodic to dependent use (47), in 
addition to the drug target residue (due to varying excretion profiles), and the size of 
the population served by the WWTP (9).  
With regular, long-term sampling, wastewater data could reliably estimate the 
direction of trends in stimulant use. However, while the current focus is on much 
sparser sampling, it is unlikely that wastewater data will be robust enough to be the 
sole information on consumption trends. Further, local information (e.g. on purity and 
patterns of use) is required to interpret the evidence. Our case study in Eindhoven 
illustrated the difficulty in assessing long-term trends with sparse wastewater data 
and few other regional indicators of stimulant consumption. For robust comparisons 
of wastewater data with other indicators, sampling should be targeted at locations 
known to have commensurate epidemiological data on drug use and where other 
indicators of stimulant use can be mapped approximately to the catchment of the 
WWTP.  
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Figure 1. A-B: regional (Oslo) data, C-D: national (Norway) data. Number of recorded driving under 
the influence offences (A), seizures* (B), positive results from autopsy (C-blue) and prison (C-green) 
data for MDMA from 2009 to 2017: observed data and Poisson log-linear trends with 95% confidence 
intervals (CIs). D: Estimated prevalence of MDMA use in Norway amongst 15 to 64 year olds* based 





Figure 2. A: Estimated daily population-normalised loads of MDMA in wastewater in Oslo 2009 to 
2017 (light blue), with estimated averages for each year from the annual effects model (dark blue) and 
a trendline for the log-linear model (green), with 95% Cr-Is. B: Estimated daily population-normalised 
loads of MDMA in wastewater by day of the week with 95% Cr-Is, calibrated to 2009.  
Indicator MDMA 
Wastewater (R) 55.1% (47.8, 62.8%) 
Number of recorded DUI (R) 35.4% (22.2,50.0%) 
Number of police seizures (R) 49.2%  (36.4, 63.3%) 
Number of positive autopsy results (N) 45.4% (26.9, 66.6%) 
Number of positive results in prison (N) 47.2% (34.0, 61.8%) 
Prevalence (N) 39.5% (13.1, 72.0%) 
Table 1. Estimated average annual percentage change (with 95% confidence intervals) in regional (R) 
and national (N) indicators of MDMA use in Oslo/Norway.  





𝐷 pD DIC 𝐷 pD DIC 𝐷 pD DIC 





394.6 155.4 550.0 -178.2 99.8 -78.4 -68.2 80.9 12.7 
Model (iii):  
linear trend 
394.3 154.6 548.9 -187.0 228.7 41.7 -69.1 111.7 42.6 
Table 2. Deviance Information Criterion (DIC) comparison between wastewater regression models 
fitted to each location (and drug target residue). pD is a measure of complexity of the model, 𝐷 is the 
posterior mean of the deviance and DIC = pD + 𝐷. The best fitting model after penalising for 
complexity (model with the lowest DIC) for each location is indicated by bold font. 
 
Figure 3. A: Numbers of methamphetamine-related hospital admissions (blue), emergency 
department presentations (green) and psychiatric admissions (red) in Queensland from 2010 to 2016, 
with fitted Poisson log-linear trends and 95% CIs. We note that there is some overlap between 
hospital admissions and emergency department presentations (29). B: Number of seizures (green) in 
SE Queensland 2010 to 2015 and number of methamphetamine-related deaths (blue) in Australia 
2009 to 2015, with fitted Poisson log-linear trends and 95% CIs. 
 
Figure 4. A: Estimated daily population-normalised loads of methamphetamine in wastewater in the 
SE Queensland region 2009-2017 (light blue), with estimated averages for each year from the annual 
and quarterly effects model (dark blue) and a trendline for the log-linear model (green), with 95% Cr-
Is. Purity-adjusted estimated yearly averages are displayed in red with 95% Cr-Is. B: Estimated daily 
population-normalised loads of methamphetamine in wastewater by day of the week, with 95% Cr-Is, 
calibrated to the 1st quarter of 2009.  
Indicator Methamphetamine 
Wastewater (R) 31.1% (29.4, 32.9%) 
Number of police seizures (R) 14.1% (10.9, 17.3%) 
Number of hospital admissions (S) 63.3% (61.0, 65.7%) 
Number of emergency department presentations (S) 39.6% (37.1, 42.1%) 
Number of psychiatric admissions (S) 71.3% (66.0, 76.7%) 
Numbers of methamphetamine-related deaths (N) 13.1% (10.4, 15.9%) 
Table 3. Estimated average annual percentage change (with 95% confidence intervals) in regional 
(R), state (S) and national (N) indicators of methamphetamine use in SE 
Queensland/Queensland/Australia.	 
 
Figure 5. A: Total number of people attending treatment in each month with cocaine as their primary 
problem (blue) or secondary problem (red) in the Eindhoven region 2012-2017: observed data and 
fitted Poisson log-linear trend, with 95% CIs. B: Annual numbers of DUI (red) and deaths (blue) due to 





Figure 6. A: Estimated daily population-normalised loads of benzoylecgonine in wastewater in 
Eindhoven 2012-2017 (light blue), with estimated averages from the annual effects model (dark blue) 
and a trendline for the log-linear model (green), with 95% Cr-Is. B: Estimated daily population-
normalised loads of benzoylecgonine in wastewater by day of the week, with 95% Cr-Is, calibrated to 
2012. 
Indicator Cocaine 
Wastewater (R) 1.9% (-1.0, 4.9%) 
Treatment demand – primary (R) -7.8% (-8.6, -6.9%) 
Treatment demand – secondary (R) -12.3% (-13.1, -11.6%) 
Numbers of recorded DUI (N) 16.8% (9.2, 25.1%) 
Number of recorded cocaine-related deaths (N) 20.4% (2.8, 41.1%) 
Table 4. Estimated average annual percentage change (with 95% confidence intervals) in regional (R) 
and national (N) indicators of cocaine use in Eindhoven/Netherlands.  
 
 
Figure 7.  Estimates of average daily wastewater loads per year in Oslo from EMCDDA data (red) 
versus non-EMCDDA (green) and all other weekly averages from the same year (blue) with 95% Cr-
Is, for benzoylecgonine, MDMA, methamphetamine and amphetamine. *There were no EMCDDA 
data (red) for amphetamine in 2014, but there were other seven-day consecutive periods of sampling 
in 2014 (blue). 
